Cortellis regulatory intelligence

Author: h | 2025-04-24

Product Cortellis Regulatory Intelligence Navigate the regulatory landscape and efficiently drive strategic decisions with Cortellis Regulatory Intelligence. Get full and timely coverage of global Cortellis Regulatory Intelligence. Global Regulatory Comparison Clarivate Analytics Description Cortellis Competitive Intelligence combines the same information used by pharmaceutical

AstraZeneca training: Cortellis Regulatory Intelligence

“This means we can better support our customers and alliance partners via a secure, single point of access to the entire continuum of Cortellis solutions, applications and data sets. By applying Cortellis intelligence – whether through licensed subscriptions, direct data feeds or API-enabled integration – our customers gain significant operating efficiencies and can confidently make the data-driven decisions required to accelerate pharmaceutical and medical device/diagnostic innovation.”The expertly-curated content in Cortellis spans drug discovery through IND and NDA submission and includes scientific, patent, regulatory, clinical trial and commercial intelligence. Key applications include:Cortellis Competitive Intelligence, Cortellis Deals Intelligence, and Cortellis Trials Intelligence: Includes intelligence to enable data-driven business development and portfolio strategy decisions using insights spanning 70,000+ pipeline targets, 90,000+ deals and 325,000 clinical trials.Cortellis Regulatory Intelligence: Provides comprehensive coverage and actionable insights on global regulatory information for drugs, biologics, medical devices and IVDs spanning 80 countries.Cortellis CMC Intelligence: Simplifies regulatory submissions for small molecule drugs with granular chemistry, manufacturing and control data across 130+ countries.Newport, a Cortellis solution: Enables the industry’s most advanced approach to generics product targeting, global business development and API intelligence, including intelligence on 1.2 million patents spanning 66,000 companies and 77 countries.Integrity, a Cortellis solution: Serves as a single platform to drive successful drug research and development across biology, chemistry and pharmacology activities with intelligence spanning 540,000+ bioactive compounds and 2.4 million pharmacological studies, plus pathway insights on 5,700+ drug targets.Metacore, a Cortellis solution: Delivers essential data and analytics on biological systems, including more than 1.7 million Unlock stock picks and a broker-level newsfeed that powers Wall Street. In This Article: Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics , /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions. (PRNewsfoto/Clarivate Analytics) CMC activities account for nearly 18% of the entire R&D budget, emphasizing the importance of optimization and validation. Cortellis CMC Intelligence for post-approval variations enables clients to compare requirements across 64 countries, reducing tracking time and increasing submission rates with organized, timely, and accurate information. Justin Hubbard, Vice President, Product Management, Life Sciences & Healthcare, Clarivate, said: "This enhancement underscores our commitment to simplifying the complexities of CMC regulatory dossier submissions for our clients. By offering transformative insights, Clarivate accelerates their path to markets and patients. With the ability to efficiently compare regulations across countries for small molecules and biologics, as well as automate CMC regulatory monitoring through user-configured alerts, clients can navigate the process with confidence." With its new module covering both pre- and post-approval documents, Cortellis CMC Intelligence offers comprehensive lifecycle information for drugs and biologics. Serving as a single-platform solution for CMC requirements, it effectively reduces tracking time and unnecessary costs. About Cortellis CMC Intelligence Cortellis CMC Intelligence curates and tracks official CMC regulations and local practices for more than 135+ countries, territories and organizations for small molecules and 64 countries, territories and regions for biologics, with pre-and post-approval module coverage. Robust data is available for 25+ product and regulatory-related filters based on eCTD structure, including 6K+ source documents and over 2K links to Cortellis Regulatory Intelligence, providing access to expanded detail and in-depth summaries from experts in local regulatory practices, paired with reference source documents, to offer a complete picture. The addition of a new post-approval module now makes a comprehensive CMC solution with complete lifecycle information for drugs and biologics to increase submission rates and avoid costly delays. To learn more about Cortellis CMC Intelligence, visit here.

What is new in Cortellis Regulatory Intelligence? - LinkedIn

Medtech regulatory data, insights and expertise to increase approval rates and ensure continuous compliance Accelerate your path to patients safely with Medtech regulatory intelligence Understanding and meeting ever-changing regulatory requirements is challenging and time-consuming. Our regulatory solutions and expertise help guide you to the path to faster approvals and greater patient safety. Achieve regulatory excellence We make it easy to stay on top of regulatory changes across all markets, so your regulatory affairs team can plan ahead and focus on successful submissions and continuous compliance. Enhanced efficiency Rely on our Medtech regulatory solutions to find needed regulatory info, including historic approvals and inspections, in minutes. Invest your time saved into charting the most efficient route(s) to approval. Proactive compliance Maintain compliance throughout the device life cycle with access to up-to-date comprehensive regulatory intelligence, empowering faster, informed decisions centered on device safety. Industry-leading Medtech regulatory expertise Leverage the deep knowledge of our regulatory experts, either as part of your subscription or in a custom consulting project, to increase approval rates, stay compliant, and move to new markets. Our solutions Cortellis Regulatory Intelligence - Pharma regulatory data & solutions Keep up to date with regulations, maintain biopharma and medtech regulatory compliance and make the right strategic decisions Medical Device Literature Reviews for EU MDR Clinical Evaluation Reports The Dialog platform is the most comprehensive way to perform medical device literature reviews for EU MDR Clinical Evaluation Reports Life Sciences and Healthcare Consulting Services Improving patient lives by helping clients discover, develop and bring new treatments and devices to market Clarivate Regulatory Intelligence Tracking App (ClaRITA) Streamline business-specific regulatory monitoring and impact assessments Get Started with Medtech Regulatory Services Let’s chat about working together to solve your regulatory and compliance challenges Cortellis Regulatory Intelligence enables quick identification of regulatory intelligence and diversities across multiple countries to support strategic planning. Regulatory professional Medical device manufacturer Medtech Regulatory Intelligence provides: English Machine Translations professional English translations Resources Report Regulatory evolution for IVD market growth The in vitro diagnostics (IVD) market is experiencing a significant transformation due to an increased demand for IVDs, technological advancements, an. Product Cortellis Regulatory Intelligence Navigate the regulatory landscape and efficiently drive strategic decisions with Cortellis Regulatory Intelligence. Get full and timely coverage of global Cortellis Regulatory Intelligence. Global Regulatory Comparison Clarivate Analytics Description Cortellis Competitive Intelligence combines the same information used by pharmaceutical

What’s new in Cortellis Regulatory Intelligence? - LinkedIn

(5 February 2019, Philadelphia, USA) Clarivate Analytics, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today launched Cortellis Cloud, an integrated, scalable technology platform that serves as a single point of access to Cortellis, the company’s suite of life science intelligence solutions. Along with hosting Cortellis, Cortellis Cloud supports direct feeds of industry-leading R&D content to customers and partners along with cloud applications that enable integration of Cortellis content into partner and third-party applications.With the exponential proliferation of data and an increasingly complex development landscape, drug, device and diagnostic researchers need more efficient and effective methods to collect, analyze and apply information across the entire R&D lifecycle. Built on Amazon Web Services (AWS), Cortellis Cloud enables integrated data models that support seamless connectivity across Cortellis solutions, enhancing collaboration via access to on-demand, enterprise-wide R&D intelligence.Cortellis Cloud harmonizes datapoints from thousands of sources within a single unified platform, making it the industry’s richest resource for data-driven insights and advanced analytics for Life Science professionals. New Cortellis features and additional data assets will be rapidly deployed as they become available, making it easy for users to immediately adopt the latest content and product enhancements. Through the platform, Cortellis delivers real-time insights, predictive analytics, and advanced intelligence solutions powered by machine learning and artificial intelligence capabilities.“Cortellis Cloud allows us to ingest, integrate, synthesize and share high volumes of information from a variety of sources and in disparate formats,” says Mukhtar Ahmed, President, Life Sciences, Clarivate Analytics. Brussels & Washington, 21 July 2022 – Enhesa, the leading provider of global regulatory and sustainability intelligence is pleased to announce it has completed the acquisition of RegScan, a trusted provider of global compliance solutions for environmental, health, safety & sustainability (EHS&S) professionals. The acquisition brings together two global EHS&S regulatory compliance companies, creating a unique global intelligence offering focused on helping multinational corporations create a more sustainable future.RegScan was founded in 1987 in Williamsport, PA. The business now publishes environmental, health, safety and sustainability regulatory compliance content across over 250 jurisdictions globally. RegScan is focused primarily on serving multi-national companies based in the U.S.“Today is the start of a new era in regulatory and sustainability intelligence in which Enhesa and RegScan will combine their respective content libraries to provide a unique offering to the marketplace. Blending content sets and compliance management approaches will create a truly world-class resource for EHS&S-intelligence,” said Peter Schramme, CEO at Enhesa, “I am excited for the RegScan team to join the Enhesa family. Our mission at Enhesa is to empower businesses globally to create a more sustainable future – RegScan will help us achieve that mission faster with its deep domain expertise, proven processes, and strong foothold in the US. Our combined client bases – and the market in general – will benefit from enhanced content from a single global partner, including amongst others: global EHS intelligence, ESG-compliance and global guidance, market-leading product compliance content, chemical management content and leading sustainable chemistry intelligence.”The deal marks the fifth acquisition for Enhesa since CGE Partners backed the company in July 2020. Consistently expanding its capabilities to provide a truly comprehensive, 360° view of global operations, product and chemicals management compliance and sustainability, Enhesa acquired Chemical Watch, the leading global provider of independent intelligence and insights for product safety professionals managing chemicals, in 2020, Scivera, the leader in sustainable chemistry, in 2021, HCB, the leading publisher of key insights on the transport, handling and storage of dangerous goods, in 2021, and ToxPlanet the leading source of chemical safety data and decision support solutions to help businesses manage the impact of chemicals on people, the workplace, and the environment, in 2022.Ned Ertel, President and CEO of RegScan, Inc. added, “RegScan has provided world-class service to our clients for over 30 years, and our employees will look to continue that excellence as part of a larger, more global platform.

Request a free trial of Cortellis Regulatory Intelligence

Skip to content 3E --> SolutionsChemical & Workplace Safety Chemical & Workplace Safety Solutions Chemical Inventory and SDS ManagementRegulatory News and InsightsEmergency ResponseDisclosure Permit and Support Capabilities Chemical Inventory ManagementSDS Data ObtainmentSDS IndexationGlobal Regulatory NewsExpert Regulatory and Industry AnalysisProduct and Material Ingredient ScreeningClassification ServicesManaged Data Service Supplier OutreachTrusted Supplier NetworkPartner Integrations Product Stewardship Product Stewardship Solutions SDS AuthoringHorizon ScanningMarketability and Commercial Decision SupportIntegrated Regulatory Content Capabilities SAP IntegrationPartner IntegrationsSDS Data ObtainmentSDS IndexationClassification ServicesProduct and Material Ingredient ScreeningGlobal Regulatory NewsExpert Regulatory and Industry AnalysisPoison Centre Notifications Supply Chain Visibility Supply Chain Visibility Solutions Product TransparencyCircularityProduct ComplianceDigital Product PassportsSupply Chain Data Collection Capabilities Supplier SurveysTrusted Supplier NetworkSupplier OutreachManaged Data Service Product and Material Ingredient ScreeningReporting: Declare Labels, HPDs and moreExpert Regulatory and Industry AnalysisPartner Integrations Sustainability Sustainability Solutions PFAS Risk ManagementCircularityProduct ComplianceProduct TransparencyHorizon Scanning Capabilities Expert Regulatory and Industry AnalysisGlobal Regulatory NewsChemical Inventory ManagementProduct and Material Ingredient ScreeningClassification ServicesManaged Data Service Supplier OutreachSDS Data ObtainmentTrusted Supplier NetworkSDS IndexationSAP IntegrationPartner IntegrationsReporting: Declare Labels, HPDs and more Regulatory Requirements Global Regulatory Coverage ECHAEuropean Chemicals AgencyREACHRegistration, Evaluation, Authorisation and Restriction of ChemicalsSCIPSubstances of Concern In ProductsRoHSRestriction of Hazardous Substances GHSGlobally Harmonized System for Hazard CommunicationEPAEnvironmental Protection AgencyPFASPer- and Polyfluoroalkyl SubstancesTSCAToxic Substances Control Act CA Prop 65California Proposition 65EU PCNPoison Centre NotificationsUFLPAUyghur Forced Labor Prevention Act 3E Products Chemical & Workplace Safety Product Stewardship Supply Chain Visibility 3E ProtectSDS & Chemical Management Tool3E InsightChemical Regulatory Compliance Tool 3E GenerateSDS & Label Authoring Platform3E Authoring ServicesAutomated SDS Authoring Service3E Regulatory Intelligence APIIntegrated Regulatory Content for Third-Party Applications3E

Cortellis Regulatory Intelligence webinar: Next-level tips and tricks

By combining our collective experience and expertise, clients can expect a robust offering to meet their EHS&S compliance needs.”Ned Ertel will step down to pursue other interests following the acquisition. Media enquiriesJohn Roderick – [email protected] – p: 631.584.2200 – c: 917.923.6825 – www.jroderick.com About EnhesaEnhesa Company is the leading provider of regulatory and sustainability intelligence worldwide. Headquartered in Brussels, with offices in Washington, DC, Wilmington, NC, Toronto, the United Kingdom, Tokyo, and Shanghai, Enhesa empowers multinational corporations worldwide to create a more sustainable future – positively impacting our environment, our health, our safety, and our future. Bringing together the world’s most comprehensive data sets, AI-powered analytics, and renowned subject matter experts in the areas of global operations, product and chemicals management compliance and sustainability, Enhesa provides actionable compliance intelligence in more than 30 languages across more than 300 jurisdictions. Navigating the fast-changing regulatory landscape, Enhesa helps corporations meet their compliance and sustainability needs with confidence, now and in the future.. Product Cortellis Regulatory Intelligence Navigate the regulatory landscape and efficiently drive strategic decisions with Cortellis Regulatory Intelligence. Get full and timely coverage of global Cortellis Regulatory Intelligence. Global Regulatory Comparison Clarivate Analytics Description Cortellis Competitive Intelligence combines the same information used by pharmaceutical

‎Cortellis Regulatory Alerts on the App Store

The rule of law, and the dangers of judicial overreach and activism. Video of the event is available here: MAR 3 Analyzing President Trump’s Executive Order on Artificial Intelligence Jerome Walker, co-chair of the Presidential Task Force on Artificial Intelligence and Digital Technologies, leads a discussion on President Trump's January 23, 2025 executive order: Removing Barriers to American Leadership in Artificial Intelligence. The episode features insights from Nikhil Aggarwal, Harut Minasian, and Nichole Sterling on the implications of reversing President Biden's AI policies. Key discussions include the roles of federal and state regulations, the balance between innovation and safety, and the international landscape of AI regulations. Nikhil, Harut and Nichole also explain foundational principles like explainability, transparency, and fairness in AI models, and assess how stakeholders should navigate these regulatory changes. Additionally, the episode delves into practical examples of AI applications in national security and offers strategic advice for market participants over the next four years. If you’re interested in learning more about cryptocurrency and regulatory treatment of digital financial technology, join us for the City Bar’s Crypto Institute on March 11 ( and available thereafter on-demand). Visit nycbar.org/events to find all of the most up-to-date information about our upcoming programs and events. Removing Barriers to American Leadership in Artificial Intelligence: 00:22 Overview of President Trump's Executive Order on AI 02:34 Panelist Introductions 05:47 Understanding AI Models 08:01 AI in National Security 10:13 Impact of Executive Orders on AI Stakeholders 14:24 Legal Advice for AI Stakeholders 30:59 State Responses to